ReviewBMC musculoskeletal disorders2025
En bloc excision and customized prosthesis replacement for Campanacci III giant cell tumours of the distal radius: five cases report and a review of the literature.
Review in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGiant cell tumours of the distal radius are highly aggressive local bone tumours. En bloc resection of Campanacci grade III giant cell tumours of the distal radius has been promoted as a reliable method for achieving local control, associated with the dual problem of bone defect reconstruction and functional recovery. Through a case report and a literature review, we evaluated the local recurrence, clinical effect, and complications of prosthesis replacement for treating Campanacci III giant cell tumours of the distal radius.
methods5 patients with Campanacci III giant cell tumours of the distal radius received en bloc excision and customized prosthesis replacement from February 2016 to December 2021 in our department. Oncology efficacy, wrist range of motion, MSTS scores, and surgical complications were evaluated during follow-up. Grip strength was measured using a hydraulic hand dynamometer.
resultsFive patients were followed up for 5 to 38 months, with an average follow-up time of 18.40 ± 13.69 months. No local tumour recurrence or lung metastasis occurred by the date of the last follow-up. Functional results revealed that the average active ROM of the wrist was 38.6° (range 30°-45°) of dorsiflexion, 40.8° (range 25°-47°) of volar flexion, 31.2° (range 24°-40°) of supination, 22.2° (range 16°-30°) of pronation, 13.8° (range 10-16°) of radial deviation, 14.8° (range 12°-18°) of ulnar deviation, and mean grip strength was 59% (50-76%). The overall revised MSTS score averaged 73.8% (63-83%). One patient experienced a superficial infection one week after surgery, and the incision healed after an intravenous infusion of antibiotics. During the follow-up period, there was no wrist dislocation or prosthesis loosening.
conclusionEn bloc resection of Campanacci grade III giant cell tumours of the distal radius may reduce the local recurrence rate, and a prosthesis reconstruction is still an alternative option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.